Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Client Work

US based manufacturer of recombinant human glycoprotein conducts clinical trial program

Fasken
Reading Time 1 minute read Subscribe
Client

Confidential Client

Timothy Squire of Fasken Martineau was retained by a US based manufacturer of recombinant human glycoprotein to assist with their clinical trial program and market authorization, including protocol, agreements, classification and submission.

    Subscribe

    Receive email updates from our team

    Subscribe